Features | Partner Sites | Information | LinkXpress
Sign In
Primedic
Schiller
VIEWORKS

Capnography Monitoring Solution Increases Patient Safety

By HospiMedica International staff writers
Posted on 31 Oct 2013
Image: The Capnostream 20p bedside monitor (Photo courtesy of Covidien).
Image: The Capnostream 20p bedside monitor (Photo courtesy of Covidien).
A new capnography solution offers enhanced features that could help clinicians identify and address serious respiratory care threats sooner.

The Capnostream 20p bedside monitor features the proprietary Apnea-Sat Alert algorithm, an algorithm that measures and reports recurring apnea and oxygen desaturation events, displaying the values directly on the Capnostream 20p monitor screen without requiring additional equipment or clinical workflow changes. Apnea-Sat Alert technology is also part of the broader family of Smart Alarm Management integrated algorithms that help to mitigate alarm fatigue, including Smart Breath Detection, a filter and pattern recognition algorithm that screens out low-amplitude “non-breath” etCO2 excursions like snoring, talking or crying, to provide a more accurate respiratory rate.

Other integrated algorithms include Smart Alarm for Respiratory Analysis (SARA), an alarm management technology that helps prevent alarm fatigue by reducing clinically insignificant respiratory alarms; Nellcor SatSeconds, a technology that helps analyze oxygen desaturation events; and the Integrated Pulmonary Index (IPI) algorithm that combines four respiratory measurements—capnography, respiratory rate, pulse rate, and pulse oximetry—to provide clinicians with an integrated snapshot of respiratory status.

The Capnostream 20p bedside monitor also includes the Microstream-enabled microMediCO2 module measurement bench, a module that offers easy integration into host monitor configurations, and is designed to support future Smart Capnography algorithms without requiring hardware upgrades. The Capnostream 20p bedside monitor is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and drug Administration (FDA).

“Studies show that as many as 88% of hospitalized patients may be at risk for recurrent apneas, yet we’re only identifying and treating a very small number,” said Scott Kelley, MD, chief medical officer of respiratory and monitoring solutions at Covidien. “The Capnostream 20p bedside monitor will help increase apnea detection rates and represents an important advancement in continuous patient monitoring that we believe will help save lives.”

Related Links:

Covidien



Channels

Women's Health

view channel

Women Undergoing Heart Attack Delay Hospital Arrival

Women suffering a heart attack wait much longer than men to call emergency medical services and face significantly longer delays getting to a hospital, according to a new study. Researchers at the University of Bologna (Italy) examined records of 7,457 European patients enrolled from 2010 to 2014 in an international... Read more

Health IT

view channel
Image: Simulation of color correction using EnChroma Cx (Photo courtesy of EnChroma).

Correcting Glasses Reestablish Indoor Color Vision

Innovative glasses enable red-green color vision deficiency (CVD) sufferers see digital display screens and status indicator lights when performing color-based activities. The EnChroma Cx-65 eyewear... Read more

Business

view channel

Universal Public Drug Coverage Would Save Canada Billions

A new study claims that Canada could save CAD 7.3 billion annually by providing universal public coverage of medically necessary prescription drugs. Researchers at the University of British Columbia (UBC; Vancouver, Canada) and the University of Toronto (ON, Canada) used published data on prescribing patterns and costs... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.